Federal regulators in the United States are pushing harder than ever to reduce and eventually replace animal testing in drug ...
The FDA has released draft guidance that aims to clear up how drug developers can use alternative testing – but that doesn’t mean animal testing in the US is over.
The guidance clarifies what sponsors should consider when putting together an application for the validation of a NAM ...
The FDA has released a draft guidance outlining how drug developers can validate new approach methodologies (NAMs) as alternatives to animal testing in preclinical drug development. The guidance, ...
Non-animal testing methods could save drugmakers time and money, officials say ...